Free Trial

Tonix Pharmaceuticals (TNXP) SEC Filings & 10K Form

$0.17
0.00 (0.00%)
(As of 05/30/2024 ET)

Recent Tonix Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/24/2024
4:10 PM
Taylor Carolyn E. (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2024
7:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2024
3:56 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
3:49 PM
Tonix Pharmaceuticals (Filer)
Form ARS
04/15/2024
3:38 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
04/05/2024
3:47 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
03/29/2024
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
03/29/2024
4:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:03 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2024
8:23 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2024
8:48 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2024
4:01 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4/A
03/06/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:05 PM
SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:06 PM
MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:07 PM
SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:08 PM
LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
7:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
7:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2024
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
3:31 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2024
3:53 PM
Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
Form SC 13G
01/08/2024
4:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:33 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
01/02/2024
3:15 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
12/26/2023
4:25 PM
Tonix Pharmaceuticals (Filer)
Form DEF 14A
12/21/2023
4:28 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:15 PM
Tonix Pharmaceuticals (Filer)
Form 424B5
12/21/2023
4:04 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2023
9:31 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2023
6:00 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The Tesla Indicator Is Bullish (Ad)

If you ever thought you’re too late to see significant returns from Tesla stock… Please read this short email. Because a world class trading expert just showed me an entirely new way to target hefty returns inside shares of Tesla. It’s all thanks to one unique trade setup that’s specific to this legendary stock. It’s called the Perfect Tesla Trade. And it couldn’t be more straightforward…

>> Click here to join Lance now and he’ll teach you how to execute the Perfect Tesla Trade inside yo
12/08/2023
4:14 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2023
6:10 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:23 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
3:27 PM
Tonix Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2023
6:49 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2023
6:17 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/20/2023
3:53 PM
Tonix Pharmaceuticals (Filer)
Form PRE 14A
10/20/2023
4:07 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
3:32 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2023
3:15 PM
Tonix Pharmaceuticals (Filer)
Form 424B4
09/29/2023
3:16 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
7:35 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2023
3:36 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2023
7:28 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
8:15 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
7:31 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
6:07 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2023
6:51 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
6:15 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2023
7:35 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2023
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2023
7:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
6:30 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/18/2023
4:24 PM
Tonix Pharmaceuticals (Filer)
Form 8-K/A
07/17/2023
6:12 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
7:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
4:05 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
7:17 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
4:12 PM
Tonix Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/15/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2023
4:29 PM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
6:05 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
6:01 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2023
6:06 AM
Tonix Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:TNXP) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners